Group dynamics in telemedicine-delivered and standard multidisciplinary team meetings: results from the TELEMAM randomised trial

Ian Kunkler, Guy Fielding, Michele Macnab, Sally Swann, John Brebner, Robin Prescott, Ross Maclean, Udi Chetty, Angela Bowman, Glyn Neades, Mike Dixon, Melanie Smith, Andrew Walls, John Cairns, Robert Lee, Tom Gardner

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

We compared breast cancer professional's perceptions of group dynamics during standard face-to-face and telemedicine-delivered multidisciplinary team meetings. Staff perceptions were measured by a Group Behaviour Inventory (GBI) consisting of 35 positive statements in 10 group behaviour sub scales: physical resources, knowledge resources, shared goals, climate, discussion norms, discussion behaviours, decision making, output, satisfaction and group status. The participants were based at a cancer centre (the Edinburgh Breast Unit) and two district general hospitals (Dumfries and Galloway Royal Infirmary and Queen Margaret Hospital, Dunfermline) in southern Scotland. Thirty-three (73%) of the core breast cancer multidisciplinary team members completed a pre-trial (face-to-face) GBI and 24 (72%) completed a post telemedicine GBI. Eleven professionals completed both. Both GBIs produced high and similar mean scores for the majority of the ten sub-scales. Participants who completed a GBI questionnaire had similar, although slightly lower, levels of positive attitudes to telemedicine-delivered compared to face-to-face breast cancer multidisciplinary meetings. These findings support the role of videoconferencing for facilitating multidisciplinary team working within a managed cancer clinical network.

Original languageEnglish
Pages (from-to)55-58
Number of pages4
JournalJournal of telemedicine and telecare
Volume12
Publication statusPublished - 2006

Fingerprint

Dive into the research topics of 'Group dynamics in telemedicine-delivered and standard multidisciplinary team meetings: results from the TELEMAM randomised trial'. Together they form a unique fingerprint.

Cite this